A showcase of the first botanical drug approved by the US FDA for treating diarrheal caused by HIV/AIDS antiretroviral therapy, about the wh

Napo Pharmaceuticals Inc announced the submission of an IND application to the U.S. FDA for a new crofelemer powder for oral solution formul

Hong Kong Baptist University is set to conduct the first phase of clinical trials for a novel Chinese medicine targeting chronic constipatio

ReHeva Biosciences is announcing the first patient enrolled and dosed in the Phase I Safety Trial for the company's drug, RH324.

by Dr. Andre Boultet, Chairman and CEO of Devonian Health Group, Canada's largest botanical drug company ABSTRACT Coronavirus disease...

In 2020, a joined force by UCLA, USC, UCSD was formed to develop scientific data on a well-known Chinese herbal medicine formula, Qing...

The United States FDA has received over 800 botanical investigational new drug applications (IND) and pre-IND meeting requests (PIND) in...

“Saccharomyces boulardii (S. boulardii) is a kind of probiotic that has been considered a crucial nutritional intervention in treating...

Yiviva, a pharmaceutical company focused on developing botanical drugs, has moved its lead candidate further into an international phase...

Subject to registration with the European Medicines Agency (EMA), DanCann Pharma will handle the exclusive sales and distribution in the...

Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company developing Brilacidin, a Host Defense Protein...

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") and the Company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc....

California-based GW said it will launch the first Phase III trial studying nabiximols, which is known as Sativex outside the United...

University of Houston professor of pharmaceutics Ming Hu is developing and testing an ancient Chinese herbal medicine formula, first...

ABSTRACT Botanical drugs are plant-derived, complex mixtures which may have synergistic effects. In order to understand this disparity...

An Ivestigational New Drug Application (IND) for the use of FSD201 (ultramicronized palm itoylethanolamide, or ultramicronized PEA) to...

PA Options for Wellness was founded by Thomas Trite in 2014 and opened its first medical marijuana dispensary under the name Vytal...

In June 2018, the U.S. Food and Drug Administration approved (cannabidiol) [CBD] oral solution for the treatment of seizures associated...

More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a...

Israeli researchers have succeeded in destroying breast cancer cells after developing a new treatment that "combines the application of...